Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine

Low-specific-activity iodine-131–radiolabeled metaiodobenzylguanidine (I-131-MIBG) was introduced last century as a potential systemic therapy for patients with malignant pheochromocytomas and paragangliomas. Collective information derived from mainly retrospective studies has suggested that 30–40%...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez, Camilo, Erwin, William, Chasen, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678905/
https://www.ncbi.nlm.nih.gov/pubmed/31330766
http://dx.doi.org/10.3390/cancers11071018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678905/
https://www.ncbi.nlm.nih.gov/pubmed/31330766
http://dx.doi.org/10.3390/cancers11071018

Ejemplares similares